Clinical trials
Expanded access Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 4 |
| Approved for marketing | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CytoDyn, Inc. | 2 |
| AbbVie | 1 |
| Gilead Sciences | 1 |
| Sanofi | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 6 |
| Breast Neoplasms | 1 |
Trials
Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.